SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PPL Therapeutics
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jongmans who started this subject2/23/2001 3:26:52 AM
From: nigel bates   of 53
 
LONDON, Feb 23 (Reuters) - PPL Therapeutics (LSE: PTH.L - news) , the company that cloned Dolly the sheep, has succeeded in turning a cow's skin cell into a beating heart cell, the Financial Times reported on Friday.
The Scottish group's successful "reprogramming" of a cell could lead to the development of treatment for diseases such as diabetes, Alzheimer's and Parkinson's, the paper said.
It would be seen as an important step towards producing stem cells -- simple cells with the capacity to turn into a wide range of more complex tissue types -- without using human embryos.
The company is expected to start its pre-clinical research on human cells in the very near future, with clinical trials around four years away.
The company is due to announce its findings on Friday at the British Fertility Society's Ethics Study day...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News